LDLR and Hypercholesterolemia: The C308Y mutation results in ~ 70% loss of LDL-R activity [25], leading to substantially impaired LDL-C clearance and thereby hypercholesterolemia, which is demonstrated in this study and previous reports as well [19, 23–31].